Olema Pharmaceuticals, Inc. (OLMA) compared with its closest peers (RLAY, PGEN, VERU, CRNX, ORKA). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Relay Therapeutics, Precigen, Veru, Crinetics Pharmaceuticals, Oruka Therapeutics, Geron, Crescent Biopharma, Prelude Therapeutics, Perspective Therapeutics and Cogent Biosciences share Olema Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | $4.13B | — |
| Precigen, Inc. (PGEN) | $2.45B | — |
| Veru Inc. (VERU) | $39.40M | — |
| Crinetics Pharmaceuticals, Inc. (CRNX) | $9.01B | — |
| Oruka Therapeutics, Inc. (ORKA) | $6.12B | — |
| Geron Corporation (GERN) | $864.13M | — |
| Crescent Biopharma, Inc. (CBIO) | $717.99M | — |
| Prelude Therapeutics Incorporated (PRLD) | $366.30M | — |
| Perspective Therapeutics, Inc. (CATX) | $321.91M | — |
| Cogent Biosciences, Inc. (COGT) | $5.80B | — |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
OLMA overview · OLMA earnings · OLMA financials · OLMA KPIs · OLMA documents · OLMA ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.